Joseph Heaton

Joseph Heaton

Auto-generated profile, based on publicly available information

Joseph Heaton

Department of Medicine The Brooklyn Hospital Center Brooklyn New York USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
DRDaryl Ramai
Daryl Ramai
VPViraaj Pannu
Viraaj Pannu
Antonio FacciorussoAntonio Facciorusso
Antonio Facciorusso
BDBanreet Dhindsa
Banreet Dhindsa
JHJoseph Heaton
Joseph Heaton
MBMonique Barakat
Monique Barakat
Recent years have seen the emergence of endoscopic-ultrasound-guided liver biopsy (EUS-LB) as an effective alternative to traditional (percutaneous or transjugular) liver biopsy techniques. Comparative studies have demonstrated that both endoscopic and non-endoscopic approaches are similar in terms of diagnostic adequacy, accuracy, and adverse events; however, EUS-LB offers the advantage of reduced recovery time. Additionally, EUS-LB enables the sampling of both lobes of the liver as well as the advantage of portal pressure measurements. However, EUS-LB may be argued to have a high cost, although this procedure can be cost-effective if bundled with other endoscopic procedures. Approaches utilizing EUS-guided liver therapy, such as the administration of chemotherapeutic agents and EUS elastography, are in development, and their optimal integration into clinical care is likely to emerge in the coming years. In the present review, we evaluate the available literature on EUS-LB indications, contraindications, variations in needle biopsy techniques, comparative outcomes, advantages and disadvantages, and future trends and perspectives.

16 April 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
JHJoseph Heaton
Joseph Heaton
AAAbbas Alshami
Abbas Alshami
SISteven Imburgio
Steven Imburgio
AMAnton Mararenko
Anton Mararenko
MSMatthew Schoenfeld
Matthew Schoenfeld
JAJesus Almendral
Jesus Almendral
Background: Hypertension is a global health issue associated with increased cardiovascular morbidity and mortality. This study aimed to investigate contemporary hypertension identification and management trends following the 2017 American College of Cardiology/American Heart Association guidelines. Methods and Results: Data from the National Health and Nutrition Examination Survey conducted from 2017 to 2020 were analyzed. Participants between 20 and 79 years of age were included. Participants were stratified into different treatment groups based on indication and guideline adherence. Descriptive statistics were used to compare medication use, diagnosis rates, and blood pressure control. A total of 265 402 026 people met the inclusion criteria, of which 19.0% (n=50 349 209) were undergoing guideline antihypertensive management. In the guideline antihypertensive management group, a single antihypertensive class was used to treat 45.7% of participants, and 55.2% had uncontrolled blood pressure. Participants not undergoing guideline antihypertensive management qualified for primary prevention in 11.5% (n=24 741 999) of cases and for secondary prevention in 2.4% (n=5 070 044) of cases; of these, 66.3% (n=19 774 007) did not know they may have hypertension and were not on antihypertensive medication. Conclusions: Adherence to guidelines for antihypertensive management is suboptimal. Over half of patients undergoing guideline treatment had uncontrolled blood pressure. One‐third of qualifying participants may not be receiving treatment. Education and medical management were missing for 2 in 3 qualifying participants. Addressing these deficiencies is crucial for improving blood pressure control and reducing cardiovascular event outcomes.

1 April 2022 in Cardiovascular Revascularization Medicine
Verified
Journal Article
Closed access
JHJoseph N. Heaton
Joseph N. Heaton
AOAlexis K. Okoh
Alexis K. Okoh
SSSeungmo Suh
Seungmo Suh
EOEbru Ozturk
Ebru Ozturk
ASArash Salemi
Arash Salemi
RTRajiv Tayal
Rajiv Tayal

19 February 2023 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
JHJoseph Heaton
Joseph Heaton
SSSohrab Singh
Sohrab Singh
DNDhairya Nanavaty
Dhairya Nanavaty
AOAlexis Kofi Okoh
Alexis Kofi Okoh
SKSrinivas Kesanakurthy
Srinivas Kesanakurthy
RTRajiv Tayal
Rajiv Tayal

15 May 2023 in Journal of Cardiology
Verified
Journal Article
Closed access
AMAnton Mararenko
Anton Mararenko
NUNdausung Udongwo
Ndausung Udongwo
VPViraaj Pannu
Viraaj Pannu
BMBrett Miller
Brett Miller
AAAbbas Alshami
Abbas Alshami
JHJoseph Heaton
Joseph Heaton

27 July 2021 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDF file
JHJoseph N. Heaton
Joseph N. Heaton
NDNehal Dhaduk
Nehal Dhaduk
AOAlexis Kofi Okoh
Alexis Kofi Okoh
KDKhoi P. Dang‐Ho
Khoi P. Dang‐Ho
RTRajiv Tayal
Rajiv Tayal
SWSergio Waxman
Sergio Waxman
Introduction Primary cardiac tumors (PCT) are rare, and their contemporary outcomes are not well characterized in the literature. We assessed temporal trends in patient characteristics and management of admissions for PCT in US hospitals. Methods Admissions with the principal diagnoses of a PCT (benign neoplasm of heart: ICD-9 212.7, ICD-10 D15.1; malignant neoplasm of heart: ICD-9 164.1, ICD-10 C38.0) between 2006 and 2017 were extracted from the National Inpatient Sample. Trends in demographics and clinical profiles were evaluated. We conducted descriptive analyses on the cohort and compared outcomes between those managed medically and surgically. Results Between 2006 and 2017, 19,111 admissions had the primary diagnosis of a PCT. Of these, 91.1% were benign. Admissions were mostly female (65.0%), caucasian (72.0%), and aged more than 50 years (76.0%). The annual admission rate for PCT was similar from 2006 to 2017 (p trend > .05) and associated with congestive heart failure, diabetes, renal failure, and valvular lesions. PCTs were managed surgically in 12,811 (67.0%) of overall cases, 70.8% for benign and 28.3% for malignant tumors. Overall, the in-hospital mortality rate was 2.3%. Medically managed cases reported a 2.5% higher mortality (p < .001) than those surgically managed. Admissions with malignant tumors were more likely to expire during hospitalization than those with benign tumors (odds ratio, 9.75; 95% confidence interval 6.34–14.99; p < .001). Conclusion Admissions for primary cardiac tumors were primarily women or in their fifth or sixth decade of life. Surgical intervention is more commonly practiced and is associated with better in-hospital survival.